Updated 2013 international menopause society recommendations on menopausal hormone therapy and preventive strategies for midlife health

Authors

  • T. J. de Villiers Stellenbosch University, Cape Town, South Africa, South Africa
  • A. Pines Tel-Aviv University, Tel-Aviv, Israel, Israel
  • N. Panay Chelsea and Westminster Hospital, London, UK, United Kingdom
  • M. Gambacciani Pisa University Hospital, Pisa, Italy, Italy
  • D. F. Archer Eastern Virginia Medical School, Norfolk, VA, USA, United States
  • R. J. Baber The University of Sydney, NSW, Australia, Australia
  • S. R. Davis School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australi, Australia
  • A. A. Gompel AP-HP, Hotel-Dieu, Paris, France, France
  • V. W. Henderson Stanford University, Stanford, CA, USA, United States
  • R. Langer University of Nevada School of Medicine, Las Vegas, NV, USA, United States
  • R. A. Lobo Columbia University, New York, NY, USA, United States
  • G. Plu-Bureau Hotel Dieu, Paris, France, France
  • D. W. Sturdee Solihull Hospital, Birmingham, UK, United Kingdom

DOI:

https://doi.org/10.18370/2309-4117.2014.17.52-69

Keywords:

International Menopause Society, recommendations, hormone therapy, menopause

Abstract

In 2013 International Menopause Society published Updated 2013 Recommendations on Menopausal Hormone Therapy and Preventive Strategies for Midlife Health. These Recommendations and the subsequent key messages therefore give a global and simple overview that serves as a common platform on issues related to the various aspects of hormone treatment, which could be easily adapted and modified according to local needs. In recommending the term «menopausal hormone therapy» was used to refer estrogen, progestogen and combined therapies.

Author Biographies

T. J. de Villiers, Stellenbosch University, Cape Town, South Africa

MediClinic Panorama and Department of Obstetrics and Gynecology

A. Pines, Tel-Aviv University, Tel-Aviv, Israel

Sackler Faculty of Medicine

N. Panay, Chelsea and Westminster Hospital, London, UK

Queen Charlotte’s & Chelsea Hospital

M. Gambacciani, Pisa University Hospital, Pisa, Italy

Department of Obstetrics and Gynecology

D. F. Archer, Eastern Virginia Medical School, Norfolk, VA, USA

Jones Institute

R. J. Baber, The University of Sydney, NSW, Australia

Sydney Medical School

S. R. Davis, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australi

Department of Epidemiology and Preventive Medicine

A. A. Gompel, AP-HP, Hotel-Dieu, Paris, France

UF de Gynecologie, Universite Paris Descartes

V. W. Henderson, Stanford University, Stanford, CA, USA

Departments of Health Research & Policy (Epidemiology) and of Neurology & Neurological Sciences

R. Langer, University of Nevada School of Medicine, Las Vegas, NV, USA

Associate Dean for Clinic and Translational Research and Professor of Family Medicine-Las Vegas

R. A. Lobo, Columbia University, New York, NY, USA

Department of Obstetrics and Gynecology

G. Plu-Bureau, Hotel Dieu, Paris, France

Unite de Gynecologie Medicale

D. W. Sturdee, Solihull Hospital, Birmingham, UK

Heart of England NHS Foundation Trust

Downloads

Published

2014-07-11

How to Cite

de Villiers, T. J., Pines, A., Panay, N., Gambacciani, M., Archer, D. F., Baber, R. J., Davis, S. R., Gompel, A. A., Henderson, V. W., Langer, R., Lobo, R. A., Plu-Bureau, G., & Sturdee, D. W. (2014). Updated 2013 international menopause society recommendations on menopausal hormone therapy and preventive strategies for midlife health. REPRODUCTIVE ENDOCRINOLOGY, (17), 52–69. https://doi.org/10.18370/2309-4117.2014.17.52-69

Issue

No. 17 (2014)

Section

Management of menopause

License

Copyright (c) 2014 T. J. de Villiers, A. Pines, N. Panay, M. Gambacciani, D. F. Archer, R. J. Baber, S. R. Davis, A. A. Gompel, V. W. Henderson, R. Langer, R. A. Lobo, G. Plu-Bureau, D. W. Sturdee

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.